D
Denali Therapeutics Inc. DNLI
$15.49 $0.261.71% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue 5.74% -7.37% -13.76% 9.47% -5.43%
Gross Profit -5.74% 7.37% 13.76% -11.04% -105.15%
SG&A Expenses 28.07% 16.31% 21.36% -1.48% -3.55%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 15.76% 10.08% -7.56% 7.06% -5.70%
Operating Income -15.76% -10.08% 7.56% -8.25% -168.39%
Income Before Tax -25.34% -30.62% 3.98% -7.89% -154.00%
Income Tax Expenses -- -- 126.67% -- --
Earnings from Continuing Operations -25.34% -30.62% 3.95% -7.89% -154.00%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -25.34% -30.62% 3.95% -7.89% -154.00%
EBIT -15.76% -10.08% 7.56% -8.25% -168.39%
EBITDA -13.49% -10.12% 6.31% -8.37% -166.36%
EPS Basic -23.43% -13.97% 21.93% 12.36% -143.83%
Normalized Basic EPS -23.43% 5.86% 29.63% 12.35% -143.84%
EPS Diluted -23.43% -13.97% 21.93% 12.36% -145.12%
Normalized Diluted EPS -23.43% 5.86% 29.63% 12.35% -145.08%
Average Basic Shares Outstanding 1.55% 14.60% 23.03% 23.11% 23.19%
Average Diluted Shares Outstanding 1.55% 14.60% 23.03% 23.11% 19.80%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --